vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $162.5M, roughly 1.0× Bitcoin Depot Inc.). Bitcoin Depot Inc. runs the higher net margin — 3.4% vs -82.0%, a 85.4% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs -22.7%). Bitcoin Depot Inc. produced more free cash flow last quarter ($2.5M vs $-36.6M). Over the past eight quarters, Bitcoin Depot Inc.'s revenue compounded faster (-4.9% CAGR vs -11.5%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

BTM vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.0× larger
PTCT
$164.7M
$162.5M
BTM
Growing faster (revenue YoY)
BTM
BTM
+42.9% gap
BTM
20.1%
-22.7%
PTCT
Higher net margin
BTM
BTM
85.4% more per $
BTM
3.4%
-82.0%
PTCT
More free cash flow
BTM
BTM
$39.2M more FCF
BTM
$2.5M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
BTM
BTM
Annualised
BTM
-4.9%
-11.5%
PTCT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BTM
BTM
PTCT
PTCT
Revenue
$162.5M
$164.7M
Net Profit
$5.5M
$-135.0M
Gross Margin
Operating Margin
7.3%
-43.3%
Net Margin
3.4%
-82.0%
Revenue YoY
20.1%
-22.7%
Net Profit YoY
690.4%
-104.8%
EPS (diluted)
$0.08
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
PTCT
PTCT
Q4 25
$164.7M
Q3 25
$162.5M
$211.0M
Q2 25
$172.1M
$178.9M
Q1 25
$164.2M
$1.2B
Q4 24
$213.2M
Q3 24
$135.3M
$196.8M
Q2 24
$163.1M
$186.7M
Q1 24
$138.5M
$210.1M
Net Profit
BTM
BTM
PTCT
PTCT
Q4 25
$-135.0M
Q3 25
$5.5M
$15.9M
Q2 25
$6.1M
$-64.8M
Q1 25
$4.2M
$866.6M
Q4 24
$-65.9M
Q3 24
$-939.0K
$-106.7M
Q2 24
$-2.6M
$-99.2M
Q1 24
$-1.5M
$-91.6M
Operating Margin
BTM
BTM
PTCT
PTCT
Q4 25
-43.3%
Q3 25
7.3%
1.4%
Q2 25
9.2%
-19.5%
Q1 25
10.8%
82.5%
Q4 24
-76.2%
Q3 24
4.1%
-27.7%
Q2 24
4.7%
-21.5%
Q1 24
0.5%
-21.6%
Net Margin
BTM
BTM
PTCT
PTCT
Q4 25
-82.0%
Q3 25
3.4%
7.5%
Q2 25
3.5%
-36.3%
Q1 25
2.6%
73.7%
Q4 24
-30.9%
Q3 24
-0.7%
-54.2%
Q2 24
-1.6%
-53.1%
Q1 24
-1.1%
-43.6%
EPS (diluted)
BTM
BTM
PTCT
PTCT
Q4 25
$-1.63
Q3 25
$0.08
$0.20
Q2 25
$0.16
$-0.83
Q1 25
$0.20
$10.04
Q4 24
$-0.85
Q3 24
$-0.05
$-1.39
Q2 24
$-0.13
$-1.29
Q1 24
$-0.25
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$59.3M
$1.9B
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$21.0M
$-205.3M
Total Assets
$125.3M
$2.9B
Debt / EquityLower = less leverage
3.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
PTCT
PTCT
Q4 25
$1.9B
Q3 25
$59.3M
$1.7B
Q2 25
$48.0M
$2.0B
Q1 25
$35.0M
$2.0B
Q4 24
$1.1B
Q3 24
$32.2M
$1.0B
Q2 24
$43.9M
$1.1B
Q1 24
$42.2M
$884.8M
Total Debt
BTM
BTM
PTCT
PTCT
Q4 25
Q3 25
$67.5M
Q2 25
$66.5M
Q1 25
$56.2M
Q4 24
Q3 24
$44.5M
Q2 24
$41.2M
Q1 24
$37.6M
Stockholders' Equity
BTM
BTM
PTCT
PTCT
Q4 25
$-205.3M
Q3 25
$21.0M
$-155.8M
Q2 25
$4.7M
$-206.5M
Q1 25
$-4.6M
$-185.8M
Q4 24
$-1.1B
Q3 24
$-7.9M
$-1.1B
Q2 24
$4.4M
$-980.2M
Q1 24
$5.0M
$-893.9M
Total Assets
BTM
BTM
PTCT
PTCT
Q4 25
$2.9B
Q3 25
$125.3M
$2.6B
Q2 25
$109.1M
$2.6B
Q1 25
$89.7M
$2.7B
Q4 24
$1.7B
Q3 24
$87.4M
$1.8B
Q2 24
$97.5M
$1.9B
Q1 24
$90.1M
$1.8B
Debt / Equity
BTM
BTM
PTCT
PTCT
Q4 25
Q3 25
3.21×
Q2 25
14.18×
Q1 25
Q4 24
Q3 24
Q2 24
9.27×
Q1 24
7.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
PTCT
PTCT
Operating Cash FlowLast quarter
$6.6M
$-34.3M
Free Cash FlowOCF − Capex
$2.5M
$-36.6M
FCF MarginFCF / Revenue
1.6%
-22.3%
Capex IntensityCapex / Revenue
2.5%
1.4%
Cash ConversionOCF / Net Profit
1.20×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
PTCT
PTCT
Q4 25
$-34.3M
Q3 25
$6.6M
$-66.3M
Q2 25
$10.2M
$-58.3M
Q1 25
$16.3M
$870.1M
Q4 24
$-30.0M
Q3 24
$5.8M
$-77.0M
Q2 24
$10.1M
$-71.5M
Q1 24
$1.3M
$70.8M
Free Cash Flow
BTM
BTM
PTCT
PTCT
Q4 25
$-36.6M
Q3 25
$2.5M
$-69.7M
Q2 25
$9.8M
$-59.6M
Q1 25
$15.9M
$868.4M
Q4 24
$-33.8M
Q3 24
$-1.0M
$-77.5M
Q2 24
$7.6M
$-78.8M
Q1 24
$789.0K
$61.2M
FCF Margin
BTM
BTM
PTCT
PTCT
Q4 25
-22.3%
Q3 25
1.6%
-33.1%
Q2 25
5.7%
-33.3%
Q1 25
9.7%
73.8%
Q4 24
-15.8%
Q3 24
-0.8%
-39.4%
Q2 24
4.7%
-42.2%
Q1 24
0.6%
29.1%
Capex Intensity
BTM
BTM
PTCT
PTCT
Q4 25
1.4%
Q3 25
2.5%
1.6%
Q2 25
0.2%
0.7%
Q1 25
0.2%
0.1%
Q4 24
1.8%
Q3 24
5.0%
0.3%
Q2 24
1.5%
4.0%
Q1 24
0.4%
4.6%
Cash Conversion
BTM
BTM
PTCT
PTCT
Q4 25
Q3 25
1.20×
-4.17×
Q2 25
1.67×
Q1 25
3.88×
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons